Published in Am J Transplant on March 01, 2011
Molecular phenotypes of acute kidney injury in kidney transplants. J Am Soc Nephrol (2012) 1.15
Isolated endarteritis and kidney transplant survival: a multicenter collaborative study. J Am Soc Nephrol (2014) 0.94
The Banff 2009 Working Proposal for polyomavirus nephropathy: a critical evaluation of its utility as a determinant of clinical outcome. Am J Transplant (2012) 0.91
Reassessing the Significance of Intimal Arteritis in Kidney Transplant Biopsy Specimens. J Am Soc Nephrol (2015) 0.81
Recent advances in renal interstitial fibrosis and tubular atrophy after kidney transplantation. Fibrogenesis Tissue Repair (2014) 0.80
Challenges and considerations in diagnosing the kidney disease in deteriorating graft function. Transpl Int (2012) 0.77
Complement activation in kidney transplantation: from risk stratification to therapeutic strategies. Clin Exp Immunol (2014) 0.77
Acute and chronic antibody-mediated rejection in pediatric kidney transplantation. Pediatr Nephrol (2014) 0.77
The Spectrum of Renal Allograft Failure. PLoS One (2016) 0.77
Experimental glomerular endothelial injury in vivo. PLoS One (2013) 0.77
The Complement System and Antibody-Mediated Transplant Rejection. J Immunol (2015) 0.76
Combined thermosensitive in situ gel with AMD3100 in sutureless technique improves the survival and function of kidney transplants in mice. Am J Transl Res (2016) 0.75
Antibody-mediated vascular rejection of kidney allograft: characterization of different kidney allograft rejection phenotypes via histology, C4d deposition and donor-specific antibodies. Clin Exp Immunol (2014) 0.75
Factors Influencing Graft Outcomes Following Diagnosis of Polyomavirus -Associated Nephropathy after Renal Transplantation. PLoS One (2015) 0.75
Histopathological diagnosis of acute and chronic rejection in pediatric kidney transplantation. Pediatr Nephrol (2013) 0.75
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant (2008) 8.09
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39
Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant (2011) 4.06
Clinical decision support systems for the practice of evidence-based medicine. J Am Med Inform Assoc (2001) 3.90
20 years or more of follow-up of living kidney donors. Lancet (1992) 3.88
Development and acceptance of medical information systems: an historical overview. J Health Hum Resour Adm (1988) 3.76
Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant (2009) 3.43
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43
Limiting financial disincentives in live organ donation: a rational solution to the kidney shortage. Am J Transplant (2006) 3.31
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29
Increasing live donor kidney transplantation: a randomized controlled trial of a home-based educational intervention. Am J Transplant (2006) 3.11
International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int (1993) 3.11
Quality assurance in immunohistochemistry: results of an interlaboratory trial involving 172 pathologists. Am J Surg Pathol (2002) 3.05
Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol (2001) 2.80
Tolerance versus immunosuppression: a perspective. Am J Transplant (2008) 2.71
Pregnancy outcomes after kidney donation. Am J Transplant (2009) 2.66
Effect of waiting time on renal transplant outcome. Kidney Int (2000) 2.57
Organ donation in three major American cities with large Latino and black populations. Transplantation (1988) 2.41
Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant (2012) 2.28
Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant (2007) 2.25
De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant (2009) 2.24
Continuous measurement of cerebral cortical blood flow by laser-Doppler flowmetry in a rat stroke model. J Cereb Blood Flow Metab (1989) 2.03
American Society of Transplant Surgeons transplant center outcomes requirements--a threat to innovation. Am J Transplant (2009) 2.00
Transplantation of discordant xenografts: a review of progress. Immunol Today (1990) 2.00
FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes. Am J Transplant (2008) 1.94
A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am J Transplant (2012) 1.93
Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care (1996) 1.91
Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation (2000) 1.90
Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg (2001) 1.89
High dose-rate intraluminal irradiation in bronchogenic carcinoma. Technique and results. Chest (1993) 1.89
Increased incidence of malignancy during chronic renal failure. Lancet (1975) 1.79
Are wound complications after a kidney transplant more common with modern immunosuppression? Transplantation (2001) 1.73
Islet transplantation for brittle type 1 diabetes: the UIC protocol. Am J Transplant (2008) 1.73
Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation (1995) 1.65
Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science (1976) 1.65
Long-term follow-up of living kidney donors: quality of life after donation. Transplantation (1999) 1.65
Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant (2010) 1.65
NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am J Transplant (2010) 1.62
Complications and risks of living donor nephrectomy. Transplantation (1997) 1.61
The nature of biopsies with "borderline rejection" and prospects for eliminating this category. Am J Transplant (2011) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
CXCR4/CXCL12 expression and signalling in kidney cancer. Br J Cancer (2002) 1.59
Ischemic acute tubular necrosis induces an extensive local cytokine response. Evidence for induction of interferon-gamma, transforming growth factor-beta 1, granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10. Transplantation (1995) 1.59
The 'two, one, zero' decision: what to do with suboptimal deceased donor kidneys. Am J Transplant (2010) 1.58
Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies. Am J Transplant (2013) 1.57
The molecular phenotype of heart transplant biopsies: relationship to histopathological and clinical variables. Am J Transplant (2010) 1.54
Preimplantation diagnosis of single gene disorders by two-step oocyte genetic analysis using first and second polar body. Biochem Mol Med (1997) 1.52
Lies, damn lies, and statistics: the perils of the P value. Am J Transplant (2006) 1.50
Primum non Nocere: is chronic kidney disease staging appropriate in living kidney transplant donors? Am J Transplant (2009) 1.49
Fallopian tube torsion: laparoscopic evaluation and treatment of a rare gynecological entity. J Am Board Fam Pract (2001) 1.49
The molecular landscape of antibody-mediated kidney transplant rejection: evidence for NK involvement through CD16a Fc receptors. Am J Transplant (2015) 1.48
Preemptive retransplantation for BK virus nephropathy: successful outcome despite active viremia. Am J Transplant (2006) 1.47
Colon perforation after renal transplantation: a single-institution review. Clin Transplant (1997) 1.47
Transvaginal ultrasound in patients with low beta-human chorionic gonadotropin values: how often is the study diagnostic? Ann Emerg Med (1997) 1.47
An abasic site in DNA. Solution conformation determined by proton NMR and molecular mechanics calculations. Nucleic Acids Res (1987) 1.47
The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation (2001) 1.46
Successful transplantation after conversion of a positive crossmatch to negative by dissociation of IgM antibody. Transplantation (1989) 1.46
Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery (1977) 1.45
Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant (2007) 1.44
Selective retransplant after graft loss to nonadherence: success with a second chance. Am J Transplant (2009) 1.44